Study on CTX-009 with Gemcitabine, Cisplatin, and Durvalumab for First-line Treatment in Patients with Advanced Biliary Tract Cancers | Clinical Trial

Study on CTX-009 with Gemcitabine, Cisplatin, and Durvalumab for First-line Treatment in Patients with Advanced Biliary Tract Cancers | Clinical Trial | Right2Hope